Background: Previous work on the impact of waiting times for patients with high grade glioma found that the hazard of death increased by 2% per day from oncological presentation to commencement of radiotherapy. However, this was a heterogenous group of tumours with data collated over 20 years. Use of CT planned radiotherapy was limited and doses varied (50–70 Gy). No chemotherapy was given.